Anxiolytic effects of nicotine in zebrafish

Physiology and Behavior

Volumn 90, Issue 1, 2007, Pages 54-58

  Levin, Edward D ^a   Bencan, Zachary ^a   Cerutti, Daniel T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anxiolysis; Mecamylamine; Nicotine; Zebrafish

Indexed keywords

LIGAND; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANXIETY DISORDER; ARTICLE; COGNITION; CONTROLLED STUDY; DISCRIMINATION LEARNING; DISORIENTATION; DIVING; HABITUATION; NONHUMAN; PREDATION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SMOKING CESSATION; TRANQUILIZING ACTIVITY; ZEBRA FISH;

EID: 33845485067     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2006.08.026     Document Type: Article

References (29)

1. Arthur D., and Levin E.D. Spatial and non-spatial discrimination learning in zebrafish. Anim Cogn 4 (2001) 125-131
2. Balerio G.N., Aso E., and Maldonado R. Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology (2006) 504-513
3. Brandon T.H. Expectancies for tobacco smoking. In: Kirsh I. (Ed). How expectancies shape experience (1999), American Psychological Association 263-299
4. Brioni J.D., Oneill A.B., Kim D.J.B., Buckley M.J., Decker M.W., and Arneric S.P. Anxiolytic-like effects of the novel cholinergic channel activator Abt-418. J Pharmacol Exp Ther 271 (1994) 353-361
5. Buczek Y., Le A.D., Wang A., Stewart J., and Shaham Y. Stress reinstates nicotine seeking but not sucrose solution seeking in rats. Psychopharmacology 144 (1999) 183-188
6. Cerutti D.T., and Levin E.D. Cognitive impairment models using complementary species. In: Levin E.D., and Buccafusco J.J. (Eds). Animal models of cognitive impairment (2006), CRC Taylor and Francis, New York 315-342
7. Darland T., and Dowling J.E. Behavioral screening for cocaine sensitivity in mutagenized zebrafish. Proc Natl Acad Sci U S A 98 (2001) 11691-11696
8. DHHS. The health consequences of smoking: nicotine addiction. A report of the Surgeon General (1988), U.S. Government Printing Office
9. File S.E., Kenny P.J., and Ouagazzal A.M. Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus. Behav Neurosci 112 (1998) 1423-1429
10. Guo S. Linking genes to brain, behavior and neurological disease: what can we learn from zebrafish. Genes Brain Behav 3 (2001) 63-74
11. Hogg R.C., Raggenbass M., and Bertrand D. Nicotinic acetylcholine receptors: from structure to brain function. Rev Physiol Biochem Pharmacol 147 (2003) 1-46
12. Jarvik M.E., Caskey N.H., Rose J.E., Herskovic J.E., and Sadeghpour M. Anxiolytic effects of smoking associated with 4 stressors. Addict Behav 14 (1989) 379-386
13. Jones S., Sudweeks S., and Yakel J.L. Nicotinic receptors in the brain: correlating physiology with function. Trends Neurosci 22 (1999) 555-561
14. Levin ED. The role of nicotinic acetylcholine receptors in cognitive function. In: Clementi F., Gotti C., and Fornasari D. (Eds). Handbook of experimental pharmacology: neuronal nicotinic receptors (2000), Springer-Verlag, New York 587-602
15. Levin ED., Swain H., Donerly S., and Linney E. Developmental chlorpyrifos effects on hatchling zebrafish swimming behavior. Neurotoxicol Teratol 26 (2004) 719-723
16. Levin E.D., and Chen E. Nicotinic involvement in memory function in zebrafish. Neurotoxicol Teratol 26 (2004) 731-735
17. Levin E.D., Chrysanthis E., Yacisin K., and Linney E. Chlorpyrifos exposure of developing zebrafish: effects on survival and long-term effects on response latency and spatial discrimination. Neurotoxicol Teratol 25 (2003) 51-57
18. Levin E.D., Limpuangthip J., Rachakonda T., and Peterson M. Timing of nicotine effects on learning in zebrafish. Psychopharmacology 184 (2006) 547-552
19. Levin E.D., McClernon F.J., and Rezvani A.H. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification and anatomic localization. Psychopharmacology 184 (2006) 523-539
20. Levin E.D., and Rezvani A.H. Development of nicotinic drug therapy for cognitive disorders. Eur J Pharmacol 393 (2000) 141-146
21. Levin E.D., and Simon B.B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology 138 (1998) 217-230
22. Mueller T., Vernier P., and Wullimann M.F. The adult central nervous cholinergic system of a neurogenetic model animal, the zebrafish Danio rerio. Brain Res 1011 (2004) 156-169
23. Peitsaro N., Kaslin J., Anichtchik O.V., and Panula P. Modulation of the histaminergic system and behaviour by alpha-fluoromethylhistidine in zebrafish. J Neurochem 86 (2003) 432-441
24. Picciotto M.R. Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol Sci 24 (2003) 493-499
25. Pomerleau O.F. Nicotine as a psychoactive drug: anxiety and pain reduction. Psychopharmacol Bull 22 (1986) 865-869
26. Radcliffe K.A., Fisher J.L., Gray R., and Dani J.A. Nicotinic modulation of glutamate and GABA synaptic transmission of hippocampal neurons. Ann NY Acad Sci 868 (1999) 591-610
27. Williams F.E., White D., and Messer W.S. A simple spatial alternation task for assessing memory function in zebrafish. Behav Processes 58 (2002) 125-132
28. Wonnacott S., Irons J., Rapier C., Thorne B., and Lunt G.G. Presynaptic modulation of transmitter release by nicotinic receptors. In: Nordberg A., Fuxe K., Holmstedt B., and Sundwall A. (Eds). Progress in Brain Research vol. 79 (1989), Elsevier Science Publishers B.V. 157-163
29. Zarrindast M.R., Homayoun H., Babaie A., Etminani A., and Gharib B. Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice. Eur J Pharmacol 407 (2000) 145-158